{"name":"Perha Pharmaceuticals","slug":"perha-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWklsUzM1MWV5UG9OVUZ2MDVxU0dFZXNicklodnpHb1g5UkNrT3BneEVkai14VkdVajl5MEtkUTFlWG9EWG9JYVR5Y2dDYzdSSW9IeEVDdmd6U2tVcGF3UndTcDIyYjdrV1dOdUVfWFhlM3psYU5VQXFwb29sczN2WktwRUhGWFVsakFTVG1hbElBejlYR0VIRThKX3E4aTFhd3JYZS1zMnRUcnAxYXZ1blpfNmhsd1RtTlpLNEpsWUNhQWZEWk1MWWx3blN5dU5PZlJERjFxZ001QWNLeEFKcWV4Nks4ZDdickZpMEU1VS1peDhYaGc0?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Alzheimer’s Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight - Barchart.com","headline":"Alzheimer’s Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveIns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPb0ktazBtTkJ3QWxybGtFTFFJb1N1aUhXX3BUbTFCQkpyd1pMSTdlZmhEUktWSldLRmhJV2t5SE84Zk9Za1F0THotODkxcHd5UkJYLV9nVXZHZ05Jd0lWVktBM284QWRnMHZyRy1ZY3NWMXpRUXp2TmhpME53SUhzTGgxTzMweHRRUnBzR2Y4QUVzUkxyWlpCY2E5b1F5bEVVdXhSanhBZW9Fbm5hT1pSSEF3aDhIUll2bXQwUS1FT18tMnNVS1d1TzlFSFl2OHVJcVFfdXlfdVkxU0U4YTFScVlMZjRlSTZKV0dRSDdB?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight - Barchart.com","headline":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNeVhhcmNuX3psOXhUUjBkaWxIMHhxVGNWdEx5WmJBNWVRb3M3enJlMmd1U3cwR2tfdUVWTFBET3VoX3RQOWVMREt1MWdfNzVPby11cVhiU0J1TmdINmN6Z242OXFzWDBQSmEtUFlsTTFZSGhRSlF1TjM5Y0xSWmw3ZVFkRGNidTRad1RJNkZmU0RkUkJ1ZUo1cWFhOGRKN2VUVnhfRHdIS1RDUWFmRHJMcXJEWkJ0Sm9zRVE?oc=5","date":"2026-02-11","type":"pipeline","source":"The Washington Post","summary":"Big Pharma dodges bullet in affordability hearing - The Washington Post","headline":"Big Pharma dodges bullet in affordability hearing","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-31","type":"pipeline","source":"simplywall.st","summary":"Balaxi Pharmaceuticals Limited (NSE:BALAXI) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st","headline":"Balaxi Pharmaceuticals Limited (NSE:BALAXI) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNenBONnRCUGY2d09YdVFvaVhQNzZJNFZwcGxSQmdlYmFIQlBBanJKd3NTNEV6aHpSQzJ1eHR3TmhxRDVBdE9MUEtrOGsyZlZRVi1DVlFHTmZueVJYMDJ5b00yTjJ1N3djTHJRbmpQTTBOa3M1d2Jwd2tHa1lZbGpRNW54ekdUbUNXME9PQ2RnN3E2UmpHZWZUTzJ3S0tZQkRfeTd3YXkyRERMYURvVFE?oc=5","date":"2025-12-15","type":"trial","source":"Fierce Pharma","summary":"Many consumers don't like TV drug ads' frequency, 'misleading' visuals: SiriusXM study - Fierce Pharma","headline":"Many consumers don't like TV drug ads' frequency, 'misleading' visuals: SiriusXM study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQZk9VXzFkXzFyaXFqUlR5VDVKX0RDRFJvcjFTUnFDeE91TWtGa0hsbkpLdU1qRTNyYTZXYmNfMGdSMGZyckZjSE02dk95QWg1WTFGUUJ1Ukt0V1I4Ni1lVkc4MDI4WlBMVHAtRWFOSHRMODZHWnJLeGlLUmJOcmFmZzYtRTluOGx3a05yejVTWGp5QVli?oc=5","date":"2025-07-31","type":"pipeline","source":"City Journal","summary":"Trump’s Push to Lower Drug Prices Misses the Mark - City Journal","headline":"Trump’s Push to Lower Drug Prices Misses the Mark","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5Yc1dwMF9qTF8wS0txVWxON2g5MHhBZUE4QlB2V3BTZWdmLU1acTNlbGlDN3FFYjY4RDdZRzhEaHc3NGJhVXNHM3d3OUlRTGVuOC1BRnpDUFI0T2xpUlcwSEM1V21ZMHJiNi11SDBhWWRORVRTREcxWWNncEo?oc=5","date":"2025-07-28","type":"pipeline","source":"The New York Times","summary":"Trump’s Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions - The New York Times","headline":"Trump’s Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBINmFvTWphclUzUmV0bEJGRzdmcGhmNEY1OERrR0szcS0tcFRmNEs3NUpzbzZNVTJBN2lydHM5U3gzNTJzazI0VkFGdjc3MUNwTTRhVHJuNi1MeDljb21KWnpDUlpSVVl5YVZSSjlKR0FoT3BydDRr?oc=5","date":"2023-02-09","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Introducing Value & Access - Pharmaceutical Commerce","headline":"Introducing Value & Access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQRW1SVlBfWE00Sm8xWFM1ZERIdGNMUXZ0V1hfT3dLMHBtOTNkZUJ4VF9FNGxodTcycUNDbE40ZnNDa2kwRkxWR0lVdkx6Wm1wbDl3SEg5dUZWb0xCS1N5Rm9qeWE3REZabV8zLU56S2VWdjhYTW4yb3ZUNnRhMnNhTmVndnVvcllvcEJqZXBpdkhBOUxfYXY0b3VKUDZTNlBiMEFqaGkxa3rSAa4BQVVfeXFMTUV0d0cxUVlacUs4dl9uUGItSzU2dVNrd3pzYl93dDk4SzVjeUs0dk9Na09yam1HQWdmX3hVdV9IV3B1c1BZWWw5R1pXODY3eFV3YVRnSU1Kemw4bUxZa0l4NXlWRFBRbUJ0UjhzU2U3ZkpEY2JaWm1TRUh6N0JFSVQxYVhheF9lZEFoZUpPdGhqXzhyMDZyVXdoWUpYYkRfdUJiZlVNak96c2MtSUl3?oc=5","date":"2022-06-05","type":"pipeline","source":"PBS","summary":"Mark Cuban aims to lower prescription drug prices with online pharmacy - PBS","headline":"Mark Cuban aims to lower prescription drug prices with online pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQVzBfQVRKdUY2YVVCQW0yTG5VZ2JqLXEzbmlZODRLeXI1bTZTbnRRMktHSzJ6ZElKUGNrdFFId1hUeHJUM3BBbld3Ny16Z2hHV1dsR01NdUtUYXhjeFIybXExaUtKUG9aVEVHdDFZRkNZMXQ0STRxdGV1MWtaZGoxcm9RRGdQa3NY?oc=5","date":"2019-09-23","type":"pipeline","source":"PharmTech.com","summary":"Perhaps it’s Time to Think about Sustainable Sourcing - PharmTech.com","headline":"Perhaps it’s Time to Think about Sustainable Sourcing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMWhkTlBxeG5xanIwQ0J1c2JqamttT0pqUFBfSEcySERNYlJ0NWwydmxRaWxsNE9VSDhVR0N4bHdVc3NQUXBXaDMzY29XWm1pQmE0WE9yejBHdzhiTnREcEdkMGdzZmZQbXFkZ1lkWGtLWlM1VGE4TXo4NVRXZ0stbThzV09ITTMwNWc?oc=5","date":"2019-07-19","type":"pipeline","source":"The People's Pharmacy","summary":"Aspirin the Miracle Drug Deserves Respect - The People's Pharmacy","headline":"Aspirin the Miracle Drug Deserves Respect - The People's Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9adUk2RXhSbEE0YzNzT011V0llOFQwNG84TWlmX3o2a3JkaGFPUmRDY0pZZmh1cHZKT2pYbXh3ck1GSWtpVHloMEpXcmJ2R0xXZEs5cW9SMEtfeG9od2k5aFlhVnpad0tZV3MxY0MtLXNyYWlFbDhPT1B3?oc=5","date":"2015-04-24","type":"pipeline","source":"UKNow","summary":"UK College of Pharmacy Blends Legacy and Innovation - UKNow","headline":"UK College of Pharmacy Blends Legacy and Innovation","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}